Explore the potential of invariant natural killer T (iNKT) cells in developing "off-the-shelf" cancer therapies in this 34-minute webinar presented by Dr. Lili Yang, Associate Professor at UCLA. Learn about the advantages of iNKT cells as ideal carriers for allogeneic cell therapy, their ability to target cancers without graft-versus-host disease risk, and the latest advancements in cell-based immunotherapy. Gain insights into the development of large-scale, readily distributable cell products for treating cancer patients. Watch the presentation on YouTube or the Labroots website and earn PACE credits upon completion.